Correction of Duncan's syndrome by allogeneic bone marrow transplantation

This publication has 7 references indexed in Scilit:

• Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease
  American Journal of Medical Genetics, 1991
• Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
  New England Journal of Medicine, 1991
• Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease
  Clinical and Experimental Immunology, 1991
• B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny
  Blood, 1990
• X chromosome inactivation patterns in obligate carriers of X-linked lymphoproliferative syndrome
  Clinical Immunology and Immunopathology, 1990
• Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy
  Blood, 1989
• X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)
  The Lancet, 1975